Immune response modifier conjugates
US8951528B2 · kind B2 · utility
34Cited by
60References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2007 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Dec 25, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K16/2887
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides IRM conjugates that includes an IRM moiety and a second active moiety covalently linked to the IRM moiety in which the covalent link does not depend on UV irradiation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.